PMC:7111504 / 1503-1720
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 33 | 88-97 | Species | denotes | 2019-nCoV | Tax:2697049 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 88-97 | SP_7 | denotes | 2019-nCoV |
| T91105 | 88-97 | SP_7 | denotes | 2019-nCoV |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T24 | 117-118 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 0-12 | Sentence | denotes | Conclusions: |
| T17 | 13-216 | Sentence | denotes | Given the limited time and resources to develop vaccine and treatments for 2019-nCoV, our work provides a shortlist of candidates for experimental validation and thus can accelerate development pipeline. |